Concepedia

Antonio Capacchione

AC

6

Publications

181

Citations

6

H-Index

2019

Active since

Affiliations

Merck Serono (Italy)(Current)

Federico II University Hospital

Imperial College London

University of Bari Aldo Moro

National Research Council

Antonio Capacchione is an author at Merck Serono (Italy) specializing in multiple sclerosis, clinical trials, and immunology.

Top concepts

Publications per year

2019–2021

6

Publications

6

Long-term effectiveness in patients previously treated with cladribine tablets: a real-world analysis of the Italian multiple sclerosis registry (CLARINET-MS)

Francesco Patti, Andrea Visconti, Antonio Capacchione et al. · Therapeutic Advances in Neurological Disorders · 2020 · 49 citations · Full text

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis

Marcello Moccia, Antonio Capacchione, Roberta Lanzillo et al. · Therapeutic Advances in Neurological Disorders · 2019 · 45 citations · Full text

ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial

Maria Petracca, Mario Quarantelli, Marcello Moccia et al. · Multiple Sclerosis and Related Disorders · 2021 · 43 citations

, , +5

Healthcare resource utilization and costs for multiple sclerosis management in the Campania region of Italy: Comparison between centre-based and local service healthcare delivery

Marcello Moccia, Andrea Tajani, Rosa Acampora et al. · PLoS ONE · 2019 · 18 citations · Full text

Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: a population-based study in the Campania region (southern Italy)

Marcello Moccia, Ilaria Loperto, Roberta Lanzillo et al. · BMC Health Services Research · 2020 · 16 citations · Full text

Rows per page

1–5 of 6